To access this element change to forms mode OFF
Grant Award View - GA217918
A precision medicine clinical trial platform to BEAT CF
GA ID:
GA217918
Agency:
Department of Health and Aged Care
Approval Date:
6-Dec-2021
Publish Date:
16-Feb-2022
Category:
Health and Medical Research
Grant Term:
1-Feb-2022 to 31-Jan-2025
Value (AUD):
$2,107,804.40
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
A precision medicine clinical trial platform to BEAT CF
Purpose:
Cystic Fibrosis (CF) is caused by over 2000 gene defects. Medications have been developed that improve outcomes in CF. These medicines have been shown to work in 80% of people with CF. For the remaining 20% there is uncertainty, use will be limited due to expense, some will miss out and others may receive treatment that is not needed. We have developed a personalised avatar using cells from each person that can predict accurately who will and will not benefit from these medicines.
GO ID:
GO Title:
MRFF 2021 Rare Cancers Rare Diseases Unmet Need General - Grant Opportunity
Internal Reference ID:
2021/MRF2014916
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The University of Newcastle
Recipient ABN:
15 736 576 735
Grant Recipient Location
Suburb:
Callaghan
Town/City:
Callaghan
Postcode:
2308
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, QLD
Postcode:
Multiple
Country:
AUSTRALIA